India reports that "dual mutation" virus has suspended export of vaccines for domestic needs

　　China News Service, March 25. According to foreign media reports, the outbreak in India has recently increased. On the 24th, nearly 50,000 confirmed cases of new crowns were added in a single day, and a new mutant virus with a double mutation was discovered.

It is reported that India will suspend exports of the new crown vaccine for domestic needs.

Data map: On September 21, 2020 local time, the Taj Mahal in India was reopened to the public.

The picture shows the staff disinfecting the railings.

　　According to Reuters, on the 24th local time, India reported the discovery of a new variant of the new coronavirus.

Indian officials call this mutation a "double mutation", and it was found in more than 200 samples in the western state of Maharashtra, the most severely affected state.

Maharashtra is home to Mumbai, the financial center of India.

　　Health officials said the number of tests for the new virus is not high enough to link it to the surge in cases in Maharashtra, Kerala and Punjab.

　　Epidemiologists say that the term "double variant" refers to a completely new variant that has the characteristics of two already identified variants.

According to reports, nine samples of this mutant virus were also found in New Delhi, and the number of local infections has continued to rise in the past few weeks.

　　India reported on the 24th that 47,262 new infections in the past 24 hours were the highest since the beginning of November 2020. The total number of infections reached 11.7 million; the number of deaths from the new crown increased by 275 in the past 24 hours, which is since 2021. At the most time, the total death toll reached 160,441.

　　Sources said that due to the warming of the epidemic, India has temporarily shelved all major exports of AstraZeneca vaccine produced by the Serum Institute of India to meet domestic demand.

　　The Ministry of Foreign Affairs of India and the Serum Institute of India have not yet responded to this news.

　　UNICEF, which is responsible for the procurement and distribution tasks in the global "New Crown Vaccine Implementation Plan" (COVAX), said: "As far as we know, the new crown vaccine produced by the Serological Institute of India has suffered setbacks in obtaining an export license. The delivery of vaccines to low-income economies participating in COVAX may be delayed in April."

　　The organization said: "COVAX is negotiating with the Indian government to ensure that it can be shipped as soon as possible."